Piper Brian
- SEC CIK
- 0001665924
No open-market purchases or sales filed in the past year.
Current role at each company
- SANA Sana Biotechnology, Inc.EVP, Chief Financial Officeras of Feb 18, 2026
- PRLD Prelude Therapeutics IncChief Financial Officeras of Aug 27, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Piper Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRLD Prelude Therapeutics Inc
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 (view filing) | Aug 25 | 2 days | Piper BrianChief Financial Officer | SSale | −8.33K | $33.34 | −$277.8K | −100.0%0 after | 3 lots |